250 related articles for article (PubMed ID: 24144439)
1. Characteristic expression of major histocompatibility complex and immune privilege genes in human pluripotent stem cells and their derivatives.
Chen HF; Yu CY; Chen MJ; Chou SH; Chiang MS; Chou WH; Ko BS; Huang HP; Kuo HC; Ho HN
Cell Transplant; 2015; 24(5):845-64. PubMed ID: 24144439
[TBL] [Abstract][Full Text] [Related]
2. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
[TBL] [Abstract][Full Text] [Related]
3. Immune-privileged embryonic Swiss mouse STO and STO cell-derived progenitor cells: major histocompatibility complex and cell differentiation antigen expression patterns resemble those of human embryonic stem cell lines.
Koch KS; Son KH; Maehr R; Pellicciotta I; Ploegh HL; Zanetti M; Sell S; Leffert HL
Immunology; 2006 Sep; 119(1):98-115. PubMed ID: 16836618
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming of the MHC-I and its regulation by NFκB in human-induced pluripotent stem cells.
Pick M; Ronen D; Yanuka O; Benvenisty N
Stem Cells; 2012 Dec; 30(12):2700-8. PubMed ID: 22987393
[TBL] [Abstract][Full Text] [Related]
5. Immune properties of human umbilical cord Wharton's jelly-derived cells.
Weiss ML; Anderson C; Medicetty S; Seshareddy KB; Weiss RJ; VanderWerff I; Troyer D; McIntosh KR
Stem Cells; 2008 Nov; 26(11):2865-74. PubMed ID: 18703664
[TBL] [Abstract][Full Text] [Related]
6. Heterelogous expression of mutated HLA-G decreases immunogenicity of human embryonic stem cells and their epidermal derivatives.
Zhao L; Teklemariam T; Hantash BM
Stem Cell Res; 2014 Sep; 13(2):342-54. PubMed ID: 25218797
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the immunogenicity of human iPS cell-derived neural stem/progenitor cells in vitro.
Ozaki M; Iwanami A; Nagoshi N; Kohyama J; Itakura G; Iwai H; Nishimura S; Nishiyama Y; Kawabata S; Sugai K; Iida T; Matsubayashi K; Isoda M; Kashiwagi R; Toyama Y; Matsumoto M; Okano H; Nakamura M
Stem Cell Res; 2017 Mar; 19():128-138. PubMed ID: 28135684
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells.
Suárez-Alvarez B; Rodriguez RM; Calvanese V; Blanco-Gelaz MA; Suhr ST; Ortega F; Otero J; Cibelli JB; Moore H; Fraga MF; López-Larrea C
PLoS One; 2010 Apr; 5(4):e10192. PubMed ID: 20419139
[TBL] [Abstract][Full Text] [Related]
9. Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression.
Magliocca JF; Held IK; Odorico JS
Stem Cells Dev; 2006 Oct; 15(5):707-17. PubMed ID: 17105406
[TBL] [Abstract][Full Text] [Related]
10. Comparative global immune-related gene profiling of somatic cells, human pluripotent stem cells and their derivatives: implication for human lymphocyte proliferation.
Wu CE; Yu CW; Chang KW; Chou WH; Lu CY; Ghelfi E; Wu FC; Jan PS; Huang MC; Allard P; Lin SP; Ho HN; Chen HF
Exp Mol Med; 2017 Sep; 49(9):e376. PubMed ID: 28912571
[TBL] [Abstract][Full Text] [Related]
11. Limited Immunogenicity of Human Induced Pluripotent Stem Cell-Derived Cartilages.
Kimura T; Yamashita A; Ozono K; Tsumaki N
Tissue Eng Part A; 2016 Dec; 22(23-24):1367-1375. PubMed ID: 27762664
[TBL] [Abstract][Full Text] [Related]
12. Negligible immunogenicity of induced pluripotent stem cells derived from human skin fibroblasts.
Lu Q; Yu M; Shen C; Chen X; Feng T; Yao Y; Li J; Li H; Tu W
PLoS One; 2014; 9(12):e114949. PubMed ID: 25503995
[TBL] [Abstract][Full Text] [Related]
13. HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives.
Säljö K; Barone A; Mölne J; Rydberg L; Teneberg S; Breimer ME
Sci Rep; 2017 Oct; 7(1):13072. PubMed ID: 29026098
[TBL] [Abstract][Full Text] [Related]
14. Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1.
Kruse V; Hamann C; Monecke S; Cyganek L; Elsner L; Hübscher D; Walter L; Streckfuss-Bömeke K; Guan K; Dressel R
PLoS One; 2015; 10(5):e0125544. PubMed ID: 25950680
[TBL] [Abstract][Full Text] [Related]
15. Differential role of natural killer group 2D in recognition and cytotoxicity of hepatocyte-like cells derived from embryonic stem cells and induced pluripotent stem cells.
Cisneros T; Dillard DW; Qu X; Arredondo-Guerrero J; Castro M; Schaffert S; Martin R; Esquivel CO; Krams SM; Martinez OM
Am J Transplant; 2019 Jun; 19(6):1652-1662. PubMed ID: 30549427
[TBL] [Abstract][Full Text] [Related]
16. Inability of human induced pluripotent stem cell-hematopoietic derivatives to downregulate microRNAs in vivo reveals a block in xenograft hematopoietic regeneration.
Risueño RM; Sachlos E; Lee JH; Lee JB; Hong SH; Szabo E; Bhatia M
Stem Cells; 2012 Feb; 30(2):131-9. PubMed ID: 22131151
[TBL] [Abstract][Full Text] [Related]
17. Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency.
Polanco JC; Ho MS; Wang B; Zhou Q; Wolvetang E; Mason E; Wells CA; Kolle G; Grimmond SM; Bertoncello I; O'Brien C; Laslett AL
Stem Cells; 2013 Aug; 31(8):1498-510. PubMed ID: 23728894
[TBL] [Abstract][Full Text] [Related]
18. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
19. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
20. Selective elimination of undifferentiated human pluripotent stem cells using pluripotent state-specific immunogenic antigen Glypican-3.
Okada M; Tada Y; Seki T; Tohyama S; Fujita J; Suzuki T; Shimomura M; Ofuji K; Kishino Y; Nakajima K; Tanosaki S; Someya S; Kanazawa H; Senju S; Nakatsura T; Fukuda K
Biochem Biophys Res Commun; 2019 Apr; 511(3):711-717. PubMed ID: 30827508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
